39W: (2S,3aS,10Z,11aS,12aR)-2-({8-fluoro-7-methoxy-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)-5-methyl-N-[(1-methylcyclopropyl)sulfonyl]-4,14-dioxo-1,2,3,3a,4,5,6,7,8,9,11a,12,13,14-tetradecahydro-12aH-cyclopropa[m]pyrrolo[1,2-c][1,3,6]triazacyclotetradecine-12a-carboxamide
39W is a Ligand Of Interest in 4U01 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
4U01_39W_C_301 | 63% | 9% | 0.177 | 0.973 | 2.01 | 2.57 | 9 | 18 | 1 | 0 | 100% | 1 |
4U01_39W_B_301 | 61% | 9% | 0.174 | 0.965 | 2.18 | 2.54 | 8 | 20 | 0 | 0 | 100% | 1 |
4U01_39W_D_301 | 56% | 7% | 0.203 | 0.976 | 2.21 | 2.81 | 7 | 23 | 4 | 0 | 100% | 1 |
4U01_39W_F_301 | 54% | 10% | 0.198 | 0.965 | 2.11 | 2.35 | 8 | 19 | 0 | 0 | 100% | 1 |
4U01_39W_H_301 | 52% | 9% | 0.2 | 0.958 | 2.14 | 2.53 | 8 | 19 | 1 | 0 | 100% | 1 |
4U01_39W_E_301 | 50% | 11% | 0.205 | 0.957 | 2.05 | 2.32 | 9 | 20 | 3 | 0 | 100% | 1 |
4U01_39W_G_301 | 50% | 9% | 0.201 | 0.952 | 2.03 | 2.56 | 9 | 21 | 0 | 0 | 100% | 1 |
4U01_39W_A_301 | 49% | 9% | 0.21 | 0.958 | 2.17 | 2.52 | 8 | 16 | 2 | 0 | 100% | 1 |
4U01_39W_J_301 | 40% | 11% | 0.2 | 0.911 | 2.12 | 2.23 | 9 | 19 | 0 | 0 | 100% | 1 |